SeaX Ventures 向 Skribe Medical 投资约 1215 万元支持 AI 心脏监测贴片
SeaX Ventures bets US$1.65M on Skribe Medical’s AI heart patch for cancer patients
SeaX Ventures 给 Skribe Medical 投了 165 万美元，做的是给癌症患者戴的 AI 心脏贴片，用连续监测替代反复跑医院做超声。化疗药伤心脏这个问题很多被忽视，做医疗 AI 或可穿戴设备的开发者可以看看这个切入角度。
东南亚风投机构 SeaX Ventures 向医疗科技公司 Skribe Medical 投入 165 万美元，支持其面向癌症患者的 AI 心脏监测贴片。该贴片针对癌症治疗相关心功能障碍（CTRCD）——部分缩瘤疗法会削弱心脏功能，早期发现依赖反复的超声心动图检查。
现有筛查流程需要单独预约、专职超声技师操作，且肿瘤科医生常需暂停治疗等待心脏评估结果。Skribe 的贴片方案让患者可持续佩戴监测，减少对人工超声检查的依赖，降低治疗中断的风险。
这类可穿戴+AI 的早期筛查思路，正在成为东南亚资本关注的医疗 AI 方向之一，对肿瘤科临床流程和医疗级可穿戴设备开发者都有参考意义。
SeaX Ventures bets US$1.65M on Skribe Medical’s AI heart patch for cancer patients
Surviving cancer can come with a cruel footnote. Some of the therapies that shrink tumours can quietly weaken the heart. Clinicians call it cancer therapy-related cardiac dysfunction (CTRCD), and catching it early usually means repeated echocardiograms, the heart ultrasounds that demand separate appointments, trained sonographers and, too often, a pause in treatment while oncologists wait […] The post SeaX Ventures bets US$1.65M on Skribe Medical’s AI heart patch for cancer patients appeared first on e27 .
This report is categorized under AITOP's "Industry" desk, focusing on Southeast Asia and the ASEAN-6 (Singapore, Malaysia, Indonesia, Thailand, Vietnam, Philippines) digital economy. Within our cross-regional analytical framework, it directly maps to Southeast Asia AI venture funding, M&A, and data-centre infrastructure. Key entities and technical topics under continuous tracking include SeaX Ventures, Skribe Medical, AI医疗, 可穿戴设备.
Source attribution: curated from e27 (@Sainul).
